Challenges of providing maintenance hemodialysis in a resource poor country: Experience from a single teaching hospital in Lagos, Southwest Nigeria

Hemodialysis International

Volumn 17, Issue 3, 2013, Pages 427-433

  Bello, Babawale T ^a   Raji, Yemi R ^b   Sanusi, Ibilola ^b   Braimoh, Rotimi W ^a   Amira, Oluwatoyin C ^a   Mabayoje, Omolara M ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

Blood transfusion; Maintenance hemodialysis; Vascular access

Indexed keywords

BICARBONATE; CHLORIDE; CREATININE; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; POTASSIUM; SODIUM; UREA;

ADOLESCENT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD TRANSFUSION; CHILD; CHLORIDE BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CREATININE BLOOD LEVEL; DEVELOPING COUNTRY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; IRON THERAPY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NIGERIA; OBSTRUCTIVE UROPATHY; POTASSIUM BLOOD LEVEL; SCHOOL CHILD; SODIUM BLOOD LEVEL; TEACHING HOSPITAL; TREATMENT OUTCOME; UREA BLOOD LEVEL; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; HOSPITALS, TEACHING; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NIGERIA; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84879601292     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12024     Document Type: Article

References (35)

1. Coresh J, Selvin E, Stevens LA. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298:2038-2047.
2. Mathers C, Fat DA, Boerma JT, World Health Organisation. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO; 2008.
3. Naicker S. Challenges for nephrology practice in Sub-Saharan Africa. Nephrol Dial Transplant. 2010; 10:727-728.
4. Naicker S. End-stage renal disease in Sub-Saharan and South Africa. Kidney Int. 2003; 83(Suppl):S119-S122.
5. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999; 14(Suppl 6):31-41.
6. Trivedi H. Cost implications of caring for chronic kidney disease: Are interventions cost-effective? Adv Chronic Kidney Dis. 2010; 17:265-270.
7. Cass A, Chadban S, Gallagher M, etal. The Economic Impact of End-Stage Kidney Disease in Australia: Projections to 2020. Melbourne, Australia: Kidney Health Australia; 2010.
8. Bamgboye E. Hemodialysis: Management problems in developing countries, with Nigeria as a surrogate. Kidney Int. 2003; 63(Suppl 83):S93-S95.
9. Arogundade FA, Barsoum RS. CKD prevention in Sub-Saharan Africa: A call for governmental, non-governmental and community support. Am J Kidney Dis. 2008; 51:515-523.
10. Alasia DD, Emem-Chioma P, Wokoma FS. A single-center 7-year experience with end-stage renal disease care in Nigeria-a surrogate for the poor state of ESRD care in Nigeria and other sub-Saharan African countries: Advocacy for a global fund for ESRD care program in sub-Saharan African countries. Int J Nephrol. 2012; 2012:639653.
11. Arogundade FA, Sanusi AA, Hassan MO, Akinsola A. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: Is there a change in trend? Afr Health Sci. 2011; 11:594-601.
12. El Minshawy O. End-stage renal disease in the El-Minia Governorate, upper Egypt: An epidemiological study. Saudi J Kidney Dis Transpl. 2011; 22:1048-1054.
13. Sabi KA, Gnionsahe DA, Amedegnato D. Chronic kidney failure in Togo: Clinical, laboratory, and etiological aspects. Med Trop (Mars). 2011; 71:74-76. French.
14. Elsharif ME. Mortality rate of patients with end stage renal disease on regular haemodialysis: A single centre study. Saudi J Kidney Dis Transpl. 2011; 22:594-596.
15. Jocelyn W, Sanjeevkumar P. The coming pandemic of CKD/ESRD and the aging population. J Am Soc Nephrol. 2009; 53:34-36.
16. Ekrikpo UE, Udo AI, Ikpeme EE, Effa EE. Haemodialysis in an emerging centre in a developing country: A two year review and predictors of mortality. BMC Nephrol. 2011; 12:50.
17. Rispela LC, Padarathb A, Waltc G. Strengthening health systems for equity and social justice in South Africa: The 24th anniversary of the Centre for Health Policy. J Public Health Policy. 2011; 32:S1-S9.
18. Mabayoje MO, Bamgboye EL, Odutola TA, Mabadeje AF. Chronic renal failure at the Lagos University Teaching Hospital: A 10-year review. Transplant Proc. 1992; 24:1851-1852.
19. Odubanjo MO, Oluwasola AO, Kadiri S. Epidemiology of ESRD in Nigeria: The way forward. Int Urol Nephrol. 2011; 43:785-792.
20. Gold CH, Isaacson C, Levin J. The pathological basis of end stage renal disease in Blacks. S Afr Med J. 1982; 20:263-265.
21. Veriawa Y, du Toit E, Lawley CG, Milne FJ, Reinach SG. Hypertension as a cause of end stage renal disease in South Africa. J Hum Hypertens. 1990; 4:379-385.
22. Diallo AD, Niambey E, Beda Yao B. Chronic renal insufficiency in Cote d'Ivoire: Study of 800 hospital cases. Bull Soc Pathol Exot. 1997; 90:346-348.
23. Lengani A, Coulibaly G, Laville M, Zech P. Epidemiology of severe chronic renal failure in Burkina Faso. Sante. 1997; 7:379-383.
24. Plange-Rhule J, Phillips R, Achaempong JW, Sagger-Malik AK, Cappuccio FP, Eastwood JB. Hypertension and renal failure in Kumasi Ghana. J Hum Hypertens. 1999; 13:37-40.
25. Diouf B, Niang A, Ka EH, Badiane M, Moreira Diop T. Chronic renal failure in one Dakar Hospital department. Dakar Med. 2003; 48:185-188.
26. Eghan BA, Amoako-Atta K, Kankam CA, Nsiah-Asare A. Survival pattern of hemodialysis patients in Kumasi, Ghana: A summary of forty patients initiated on hemodialysis at a new hemodialysis unit. Hemodial Int. 2009; 13:467-471. Epub 2009 May 12.
27. US Renal Data System: USRDS. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2010.
28. Alebiosu CO, Ayodele OE. Increasing prevalence of diabetes as a cause of end stage renal disease in Nigeria. Trop Doct. 2006; 36:218-219.
29. Ojogwu LI, Anah CO. Renal failure and hypertension in Tropical Africa: A predialysis experience from Nigeria. East Afr J Med. 1983; 60:478-484.
30. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002; 39:S1-S246.
31. Gold JA, Hoffman K. Fistula First: The National Vascular Access Improvement Initiative. VMJ. 2006; 105:71-73.
32. Wagani A, Abdu A, Sanad M, Tanko B, Usman I, Dadi G. A one year review of patients undergoing treatment in a new dialysis center offering subsidised treatment. Proceedings of the 23rd annual scientific conference of the Nigerian Association of Nephrology. Benin 2011.
33. Allan JC, Robert NF, David TG, Shu-Chen C. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009; 4:S5-S11.
34. Alebiosu CO. Detrimental effects of late referral for dialysis. Afr J Health Sci. 2001; 8:78-81.
35. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005; 20:2587-2593.